Tthe leading companies in the Global Global Peptide Therapeutics market

(2023年)

The following are the leading companies in the Global Global Peptide Therapeutics market:

Pfizer Inc.
Takeda Pharmaceutical Company Limited
Eli Lilly and Company
Amgen Inc.
Novartis AG
Sanofi S.A
Lonza Inc.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Bristol-Myers Squibb Company
Eli Lilly and Company
AstraZeneca plc
Novo Nordisk A/S
Teva Pharmaceutical Industries Ltd
Growth Plus Reports studies the key trends in each category and sub-segment of the Global Peptide Therapeutics market, along with Global and regional projections from 2023 to 2031. Our research splits the market into product type and application segments.

SEGMENTATION

GLOBAL PEPTIDE THERAPEUTICS MARKET ANALYSIS & FORECAST, BY APPLICATION
Metabolic
Cardiovascular Disorder
Respiratory
Cancers
GIT
Anti-infection
Pain
Renal
CNS
Others
GLOBAL PEPTIDE THERAPEUTICS MARKET ANALYSIS & FORECAST, BY TYPE
Generic
Innovative
GLOBAL PEPTIDE THERAPEUTICS MARKET ANALYSIS & FORECAST, BY TYPE OF MANUFACTURERS
In-house
Outsourced
GLOBAL PEPTIDE THERAPEUTICS MARKET ANALYSIS & FORECAST, BY SYNTHESIS TECHNOLOGY
Solid Phase Peptide Synthesis (SPPS)
Liquid Phase Peptide Synthesis (LPPS)
Hybrid Technology
GLOBAL PEPTIDE THERAPEUTICS MARKET ANALYSIS & FORECAST, BY ROUTE OF ADMINISTRATION
Parenteral Route
Oral Route
Pulmonary
Mucosal
Others